ID | 1109 | |
PMID | 19949052 | |
Year | 2010 | |
Sequence | YTSLIHSLIEESQNQQ EKNEQELLELDKWAS LWNWF | |
Name | T20 | |
Length | 36 | |
N-Terminal Modification | Free | |
C-Terminal Modification | Free | |
Linear/ Cyclic | Linear | |
Chirality | L | |
Chemical Modification | None | |
Origin of Peptide | Synthetic | |
Nature of Peptide/Cargo | Fusion inhibitor | |
Mechanism | Inhibits viral genomic integration in intraepithelial vaginal leukocytes | |
Cargo Sequence/Structure | None | |
Name of cargo | Not applicable | |
Assay | Real-time PCR | |
Enhancer | Not applicable | |
Properties of enhancer | Not applicable | |
Concentration | 200 ng/ml Gag p24 of HIV-1 | |
Incubation time | 2 hours | |
Tissue permeability (value with units) | Induced a 50% inhibition of HIV-1JRCSF genomic integration in leukocytes residing within the vaginal epithelium (IC50) was 0.153 microM (0.687 ng/ml; 95% confidence interval, 0.563 to 0.84 ng/ml; n=7 independent experiments with 4 donor tissues. | |
Tissue Sample | Vaginal epithelial sheet | |
Ex vivo/In vivo/In vitro | ex vivo | |
STRUCTURE |
| |
SMILES | N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C=O)Cc1ccccc1)Cc1c[nH] c2c1cccc2)CC(=O)N)Cc1c[nH]c2c1cccc2)CC(C)C)CO)C)Cc1c [nH]c2c1cccc2)CCCCN)CC(=O)O)CC(C)C)CCC(=O)O)CC (C)C)CC(C)C)CCC(=O)O)CCC(=O)N)CCC(=O)O)CC (=O)N)CCCCN)CCC(=O)O)CCC(=O)N)CCC(=O)N)CC(=O)N) CCC(=O)N)CO)CCC(=O)O)CCC(=O)O)[C@H](CC)C) CC(C)C)CO)Cc1[nH]cnc1)[C@H](CC)C)CC(C)C)CO) [C@H](O)C)Cc1ccc(cc1)O |